Sign in
Back
A Randomized, Controlled, Double-Blind Study Comparing the Survival Benefit of Four Different Reverse Transcriptase Inhibitor Therapies (Three-Drug, Two-Drug, and Alternating Drug) for the Treatment of Advanced AIDS
Journal article

A Randomized, Controlled, Double-Blind Study Comparing the Survival Benefit of Four Different Reverse Transcriptase Inhibitor Therapies (Three-Drug, Two-Drug, and Alternating Drug) for the Treatment of Advanced AIDS

Keith Henry, Alejo Erice, Camlin Tierney, Henry H Balfour, Margaret A Fischl, Anne Kmack, Song-Heng Liou, Antoinette Kenton, Martin S Hirsch, John Phair, …
Journal of acquired immune deficiency syndromes and human retrovirology, Vol.19(4), pp.339-349
1998-12
DOI: https://doi.org/10.1097/00042560-199812010-00004
PMID: 9833742

Metrics

6 Record Views
64 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
9 Mathematics
9.92 Statistical Methods
9.92.220 Nonparametric Regression
Web Of Science research areas
Immunology
Infectious Diseases
ESI research areas
Immunology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details